Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial

PHASE4RecruitingINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

June 20, 2022

Primary Completion Date

May 1, 2024

Study Completion Date

December 1, 2024

Conditions

Postpartum PreeclampsiaHypertension in Pregnancy

Interventions

DRUG

Labetalol Oral Tablet

See Labetalol arm.

DRUG

NIFEdipine ER

See Nifedipine arm.

Trial Locations (1)

RECRUITING

Nebraska Methodist Women's Hospital, Omaha

All Listed Sponsors

lead

Nebraska Methodist Health System

OTHER